Industry Research Reports

Home > Reports > Medical Care > Diabetes Therapeutics and Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Diabetes Therapeutics and Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Medical Care

Published Date: 2024-01-24

Pages: 166 Pages

Report ld: 2331202

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Diabetes Therapeutics and Diagnostics Market Size(US$)

CAGR 2024-2030

2.5%

Market Size,2030

USD 143,500

Million

Market Snapshot

Market Size in 2024 (Value)

US$ 123,740 million

Market Forecast in 2030(Value)

US$ 143,500 million

CAGR

2.5%

Years Considered

2019-2030

Base Year

2024

Forecast Period

2024-2030

Source: Secondary research, interviews with experts, and QYResearch analysis

This report discusses the implications of the above-mentioned trends, in the context of the current size and growth of the diabetes market, in global terms as well as by the most important national markets. Companies in the relevant pharmaceutical and medical industries are discussed, with profiles of the leaders and an update on M&A activity. Five-year global sales forecasts are provided for the main drug and device categories, and breakdowns of the diabetes market are provided by country.

The global market for Diabetes Therapeutics and Diagnostics was estimated to be worth US$ 117140 million in 2023 and is forecast to a readjusted size of US$ 143500 million by 2030 with a CAGR of 2.5% during the forecast period 2024-2030

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

MARKET SEGMENTATION

By Company

77 Elektronika Kft.
A. Menarini Diagnostics S.R.L
Abbott Laboratories
Agamatrix Inc.
Animas Corp.
Ascensia
Becton Dickinson
Debiotech S.A.
Eli Lilly And Co.
Glaxo Smithkline
Inlight Solutions Inc.
Johnson & Johnson
Lifescan Inc.
Medtronic
Merck & Co.
Merck KGAA
Nipro Corp.
Novartis Pharma Ag
Novo Nordisk A/S
Owen Mumford Ltd.
Palco Labs Inc.
Roche
Sanofi
Takeda Pharmaceutical Co. Ltd.
Terumo Corp.

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Insulin
Insulin Delivery
Oral Hypoglycemic Drugs
Diagnosis And Monitoring
Others

Segment by Application

Type 1 Diabetes
Type 2 Diabetes
Gestational Diabetes
Others

biaoTi REPORT SCOPE

This report aims to provide a comprehensive presentation of the global market for Diabetes Therapeutics and Diagnostics, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Diabetes Therapeutics and Diagnostics by region & country, by Type, and by Application.

The Diabetes Therapeutics and Diagnostics market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diabetes Therapeutics and Diagnostics.

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Diabetes Therapeutics and Diagnostics manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Diabetes Therapeutics and Diagnostics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Diabetes Therapeutics and Diagnostics in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Diabetes Therapeutics and Diagnostics Product Introduction

1.2 Global Diabetes Therapeutics and Diagnostics Market Size Forecast

1.3 Diabetes Therapeutics and Diagnostics Market Trends & Drivers

1.3.1 Diabetes Therapeutics and Diagnostics Industry Trends

1.3.2 Diabetes Therapeutics and Diagnostics Market Drivers & Opportunity

1.3.3 Diabetes Therapeutics and Diagnostics Market Challenges

1.3.4 Diabetes Therapeutics and Diagnostics Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Diabetes Therapeutics and Diagnostics Players Revenue Ranking (2023)

2.2 Global Diabetes Therapeutics and Diagnostics Revenue by Company (2019-2024)

2.3 Key Companies Diabetes Therapeutics and Diagnostics Manufacturing Base Distribution and Headquarters

2.4 Key Companies Diabetes Therapeutics and Diagnostics Product Offered

2.5 Key Companies Time to Begin Mass Production of Diabetes Therapeutics and Diagnostics

2.6 Diabetes Therapeutics and Diagnostics Market Competitive Analysis

2.6.1 Diabetes Therapeutics and Diagnostics Market Concentration Rate (2019-2024)

2.6.2 Global 5 and 10 Largest Companies by Diabetes Therapeutics and Diagnostics Revenue in 2023

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetes Therapeutics and Diagnostics as of 2023)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Insulin

3.1.2 Insulin Delivery

3.1.3 Oral Hypoglycemic Drugs

3.1.4 Diagnosis And Monitoring

3.1.5 Others

3.2 Global Diabetes Therapeutics and Diagnostics Sales Value by Type

3.2.1 Global Diabetes Therapeutics and Diagnostics Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Diabetes Therapeutics and Diagnostics Sales Value, by Type (2019-2030)

3.2.3 Global Diabetes Therapeutics and Diagnostics Sales Value, by Type (%) (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Type 1 Diabetes

4.1.2 Type 2 Diabetes

4.1.3 Gestational Diabetes

4.1.4 Others

4.2 Global Diabetes Therapeutics and Diagnostics Sales Value by Application

4.2.1 Global Diabetes Therapeutics and Diagnostics Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Diabetes Therapeutics and Diagnostics Sales Value, by Application (2019-2030)

4.2.3 Global Diabetes Therapeutics and Diagnostics Sales Value, by Application (%) (2019-2030)

5 Segmentation by Region

5.1 Global Diabetes Therapeutics and Diagnostics Sales Value by Region

5.1.1 Global Diabetes Therapeutics and Diagnostics Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Diabetes Therapeutics and Diagnostics Sales Value by Region (2019-2024)

5.1.3 Global Diabetes Therapeutics and Diagnostics Sales Value by Region (2025-2030)

5.1.4 Global Diabetes Therapeutics and Diagnostics Sales Value by Region (%), (2019-2030)

5.2 North America

5.2.1 North America Diabetes Therapeutics and Diagnostics Sales Value, 2019-2030

5.2.2 North America Diabetes Therapeutics and Diagnostics Sales Value by Country (%), 2023 VS 2030

5.3 Europe

5.3.1 Europe Diabetes Therapeutics and Diagnostics Sales Value, 2019-2030

5.3.2 Europe Diabetes Therapeutics and Diagnostics Sales Value by Country (%), 2023 VS 2030

5.4 Asia Pacific

5.4.1 Asia Pacific Diabetes Therapeutics and Diagnostics Sales Value, 2019-2030

5.4.2 Asia Pacific Diabetes Therapeutics and Diagnostics Sales Value by Country (%), 2023 VS 2030

5.5 South America

5.5.1 South America Diabetes Therapeutics and Diagnostics Sales Value, 2019-2030

5.5.2 South America Diabetes Therapeutics and Diagnostics Sales Value by Country (%), 2023 VS 2030

5.6 Middle East & Africa

5.6.1 Middle East & Africa Diabetes Therapeutics and Diagnostics Sales Value, 2019-2030

5.6.2 Middle East & Africa Diabetes Therapeutics and Diagnostics Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Diabetes Therapeutics and Diagnostics Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Diabetes Therapeutics and Diagnostics Sales Value

6.3 United States

6.3.1 United States Diabetes Therapeutics and Diagnostics Sales Value, 2019-2030

6.3.2 United States Diabetes Therapeutics and Diagnostics Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Diabetes Therapeutics and Diagnostics Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Diabetes Therapeutics and Diagnostics Sales Value, 2019-2030

6.4.2 Europe Diabetes Therapeutics and Diagnostics Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Diabetes Therapeutics and Diagnostics Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Diabetes Therapeutics and Diagnostics Sales Value, 2019-2030

6.5.2 China Diabetes Therapeutics and Diagnostics Sales Value by Type (%), 2023 VS 2030

6.5.3 China Diabetes Therapeutics and Diagnostics Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Diabetes Therapeutics and Diagnostics Sales Value, 2019-2030

6.6.2 Japan Diabetes Therapeutics and Diagnostics Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Diabetes Therapeutics and Diagnostics Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Diabetes Therapeutics and Diagnostics Sales Value, 2019-2030

6.7.2 South Korea Diabetes Therapeutics and Diagnostics Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Diabetes Therapeutics and Diagnostics Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Diabetes Therapeutics and Diagnostics Sales Value, 2019-2030

6.8.2 Southeast Asia Diabetes Therapeutics and Diagnostics Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Diabetes Therapeutics and Diagnostics Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Diabetes Therapeutics and Diagnostics Sales Value, 2019-2030

6.9.2 India Diabetes Therapeutics and Diagnostics Sales Value by Type (%), 2023 VS 2030

6.9.3 India Diabetes Therapeutics and Diagnostics Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 77 Elektronika Kft.

7.1.1 77 Elektronika Kft. Profile

7.1.2 77 Elektronika Kft. Main Business

7.1.3 77 Elektronika Kft. Diabetes Therapeutics and Diagnostics Products, Services and Solutions

7.1.4 77 Elektronika Kft. Diabetes Therapeutics and Diagnostics Revenue (US$ Million) & (2019-2024)

7.1.5 77 Elektronika Kft. Recent Developments

7.2 A. Menarini Diagnostics S.R.L

7.2.1 A. Menarini Diagnostics S.R.L Profile

7.2.2 A. Menarini Diagnostics S.R.L Main Business

7.2.3 A. Menarini Diagnostics S.R.L Diabetes Therapeutics and Diagnostics Products, Services and Solutions

7.2.4 A. Menarini Diagnostics S.R.L Diabetes Therapeutics and Diagnostics Revenue (US$ Million) & (2019-2024)

7.2.5 A. Menarini Diagnostics S.R.L Recent Developments

7.3 Abbott Laboratories

7.3.1 Abbott Laboratories Profile

7.3.2 Abbott Laboratories Main Business

7.3.3 Abbott Laboratories Diabetes Therapeutics and Diagnostics Products, Services and Solutions

7.3.4 Abbott Laboratories Diabetes Therapeutics and Diagnostics Revenue (US$ Million) & (2019-2024)

7.3.5 Agamatrix Inc. Recent Developments

7.4 Agamatrix Inc.

7.4.1 Agamatrix Inc. Profile

7.4.2 Agamatrix Inc. Main Business

7.4.3 Agamatrix Inc. Diabetes Therapeutics and Diagnostics Products, Services and Solutions

7.4.4 Agamatrix Inc. Diabetes Therapeutics and Diagnostics Revenue (US$ Million) & (2019-2024)

7.4.5 Agamatrix Inc. Recent Developments

7.5 Animas Corp.

7.5.1 Animas Corp. Profile

7.5.2 Animas Corp. Main Business

7.5.3 Animas Corp. Diabetes Therapeutics and Diagnostics Products, Services and Solutions

7.5.4 Animas Corp. Diabetes Therapeutics and Diagnostics Revenue (US$ Million) & (2019-2024)

7.5.5 Animas Corp. Recent Developments

7.6 Ascensia

7.6.1 Ascensia Profile

7.6.2 Ascensia Main Business

7.6.3 Ascensia Diabetes Therapeutics and Diagnostics Products, Services and Solutions

7.6.4 Ascensia Diabetes Therapeutics and Diagnostics Revenue (US$ Million) & (2019-2024)

7.6.5 Ascensia Recent Developments

7.7 Becton Dickinson

7.7.1 Becton Dickinson Profile

7.7.2 Becton Dickinson Main Business

7.7.3 Becton Dickinson Diabetes Therapeutics and Diagnostics Products, Services and Solutions

7.7.4 Becton Dickinson Diabetes Therapeutics and Diagnostics Revenue (US$ Million) & (2019-2024)

7.7.5 Becton Dickinson Recent Developments

7.8 Debiotech S.A.

7.8.1 Debiotech S.A. Profile

7.8.2 Debiotech S.A. Main Business

7.8.3 Debiotech S.A. Diabetes Therapeutics and Diagnostics Products, Services and Solutions

7.8.4 Debiotech S.A. Diabetes Therapeutics and Diagnostics Revenue (US$ Million) & (2019-2024)

7.8.5 Debiotech S.A. Recent Developments

7.9 Eli Lilly And Co.

7.9.1 Eli Lilly And Co. Profile

7.9.2 Eli Lilly And Co. Main Business

7.9.3 Eli Lilly And Co. Diabetes Therapeutics and Diagnostics Products, Services and Solutions

7.9.4 Eli Lilly And Co. Diabetes Therapeutics and Diagnostics Revenue (US$ Million) & (2019-2024)

7.9.5 Eli Lilly And Co. Recent Developments

7.10 Glaxo Smithkline

7.10.1 Glaxo Smithkline Profile

7.10.2 Glaxo Smithkline Main Business

7.10.3 Glaxo Smithkline Diabetes Therapeutics and Diagnostics Products, Services and Solutions

7.10.4 Glaxo Smithkline Diabetes Therapeutics and Diagnostics Revenue (US$ Million) & (2019-2024)

7.10.5 Glaxo Smithkline Recent Developments

7.11 Inlight Solutions Inc.

7.11.1 Inlight Solutions Inc. Profile

7.11.2 Inlight Solutions Inc. Main Business

7.11.3 Inlight Solutions Inc. Diabetes Therapeutics and Diagnostics Products, Services and Solutions

7.11.4 Inlight Solutions Inc. Diabetes Therapeutics and Diagnostics Revenue (US$ Million) & (2019-2024)

7.11.5 Inlight Solutions Inc. Recent Developments

7.12 Johnson & Johnson

7.12.1 Johnson & Johnson Profile

7.12.2 Johnson & Johnson Main Business

7.12.3 Johnson & Johnson Diabetes Therapeutics and Diagnostics Products, Services and Solutions

7.12.4 Johnson & Johnson Diabetes Therapeutics and Diagnostics Revenue (US$ Million) & (2019-2024)

7.12.5 Johnson & Johnson Recent Developments

7.13 Lifescan Inc.

7.13.1 Lifescan Inc. Profile

7.13.2 Lifescan Inc. Main Business

7.13.3 Lifescan Inc. Diabetes Therapeutics and Diagnostics Products, Services and Solutions

7.13.4 Lifescan Inc. Diabetes Therapeutics and Diagnostics Revenue (US$ Million) & (2019-2024)

7.13.5 Lifescan Inc. Recent Developments

7.14 Medtronic

7.14.1 Medtronic Profile

7.14.2 Medtronic Main Business

7.14.3 Medtronic Diabetes Therapeutics and Diagnostics Products, Services and Solutions

7.14.4 Medtronic Diabetes Therapeutics and Diagnostics Revenue (US$ Million) & (2019-2024)

7.14.5 Medtronic Recent Developments

7.15 Merck & Co.

7.15.1 Merck & Co. Profile

7.15.2 Merck & Co. Main Business

7.15.3 Merck & Co. Diabetes Therapeutics and Diagnostics Products, Services and Solutions

7.15.4 Merck & Co. Diabetes Therapeutics and Diagnostics Revenue (US$ Million) & (2019-2024)

7.15.5 Merck & Co. Recent Developments

7.16 Merck KGAA

7.16.1 Merck KGAA Profile

7.16.2 Merck KGAA Main Business

7.16.3 Merck KGAA Diabetes Therapeutics and Diagnostics Products, Services and Solutions

7.16.4 Merck KGAA Diabetes Therapeutics and Diagnostics Revenue (US$ Million) & (2019-2024)

7.16.5 Merck KGAA Recent Developments

7.17 Nipro Corp.

7.17.1 Nipro Corp. Profile

7.17.2 Nipro Corp. Main Business

7.17.3 Nipro Corp. Diabetes Therapeutics and Diagnostics Products, Services and Solutions

7.17.4 Nipro Corp. Diabetes Therapeutics and Diagnostics Revenue (US$ Million) & (2019-2024)

7.17.5 Nipro Corp. Recent Developments

7.18 Novartis Pharma Ag

7.18.1 Novartis Pharma Ag Profile

7.18.2 Novartis Pharma Ag Main Business

7.18.3 Novartis Pharma Ag Diabetes Therapeutics and Diagnostics Products, Services and Solutions

7.18.4 Novartis Pharma Ag Diabetes Therapeutics and Diagnostics Revenue (US$ Million) & (2019-2024)

7.18.5 Novartis Pharma Ag Recent Developments

7.19 Novo Nordisk A/S

7.19.1 Novo Nordisk A/S Profile

7.19.2 Novo Nordisk A/S Main Business

7.19.3 Novo Nordisk A/S Diabetes Therapeutics and Diagnostics Products, Services and Solutions

7.19.4 Novo Nordisk A/S Diabetes Therapeutics and Diagnostics Revenue (US$ Million) & (2019-2024)

7.19.5 Novo Nordisk A/S Recent Developments

7.20 Owen Mumford Ltd.

7.20.1 Owen Mumford Ltd. Profile

7.20.2 Owen Mumford Ltd. Main Business

7.20.3 Owen Mumford Ltd. Diabetes Therapeutics and Diagnostics Products, Services and Solutions

7.20.4 Owen Mumford Ltd. Diabetes Therapeutics and Diagnostics Revenue (US$ Million) & (2019-2024)

7.20.5 Owen Mumford Ltd. Recent Developments

7.21 Palco Labs Inc.

7.21.1 Palco Labs Inc. Profile

7.21.2 Palco Labs Inc. Main Business

7.21.3 Palco Labs Inc. Diabetes Therapeutics and Diagnostics Products, Services and Solutions

7.21.4 Palco Labs Inc. Diabetes Therapeutics and Diagnostics Revenue (US$ Million) & (2019-2024)

7.21.5 Palco Labs Inc. Recent Developments

7.22 Roche

7.22.1 Roche Profile

7.22.2 Roche Main Business

7.22.3 Roche Diabetes Therapeutics and Diagnostics Products, Services and Solutions

7.22.4 Roche Diabetes Therapeutics and Diagnostics Revenue (US$ Million) & (2019-2024)

7.22.5 Roche Recent Developments

7.23 Sanofi

7.23.1 Sanofi Profile

7.23.2 Sanofi Main Business

7.23.3 Sanofi Diabetes Therapeutics and Diagnostics Products, Services and Solutions

7.23.4 Sanofi Diabetes Therapeutics and Diagnostics Revenue (US$ Million) & (2019-2024)

7.23.5 Sanofi Recent Developments

7.24 Takeda Pharmaceutical Co. Ltd.

7.24.1 Takeda Pharmaceutical Co. Ltd. Profile

7.24.2 Takeda Pharmaceutical Co. Ltd. Main Business

7.24.3 Takeda Pharmaceutical Co. Ltd. Diabetes Therapeutics and Diagnostics Products, Services and Solutions

7.24.4 Takeda Pharmaceutical Co. Ltd. Diabetes Therapeutics and Diagnostics Revenue (US$ Million) & (2019-2024)

7.24.5 Takeda Pharmaceutical Co. Ltd. Recent Developments

7.25 Terumo Corp.

7.25.1 Terumo Corp. Profile

7.25.2 Terumo Corp. Main Business

7.25.3 Terumo Corp. Diabetes Therapeutics and Diagnostics Products, Services and Solutions

7.25.4 Terumo Corp. Diabetes Therapeutics and Diagnostics Revenue (US$ Million) & (2019-2024)

7.25.5 Terumo Corp. Recent Developments

8 Industry Chain Analysis

8.1 Diabetes Therapeutics and Diagnostics Industrial Chain

8.2 Diabetes Therapeutics and Diagnostics Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Diabetes Therapeutics and Diagnostics Sales Model

8.5.2 Sales Channel

8.5.3 Diabetes Therapeutics and Diagnostics Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Diabetes Therapeutics and Diagnostics Market Trends

Table 2. Diabetes Therapeutics and Diagnostics Market Drivers & Opportunity

Table 3. Diabetes Therapeutics and Diagnostics Market Challenges

Table 4. Diabetes Therapeutics and Diagnostics Market Restraints

Table 5. Global Diabetes Therapeutics and Diagnostics Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Diabetes Therapeutics and Diagnostics Revenue Market Share by Company (2019-2024)

Table 7. Key Companies Diabetes Therapeutics and Diagnostics Manufacturing Base Distribution and Headquarters

Table 8. Key Companies Diabetes Therapeutics and Diagnostics Product Type

Table 9. Key Companies Time to Begin Mass Production of Diabetes Therapeutics and Diagnostics

Table 10. Global Diabetes Therapeutics and Diagnostics Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetes Therapeutics and Diagnostics as of 2023)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global Diabetes Therapeutics and Diagnostics Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 14. Global Diabetes Therapeutics and Diagnostics Sales Value by Type (2019-2024) & (US$ Million)

Table 15. Global Diabetes Therapeutics and Diagnostics Sales Value by Type (2025-2030) & (US$ Million)

Table 16. Global Diabetes Therapeutics and Diagnostics Sales Market Share in Value by Type (2019-2024) & (%)

Table 17. Global Diabetes Therapeutics and Diagnostics Sales Market Share in Value by Type (2025-2030) & (%)

Table 18. Global Diabetes Therapeutics and Diagnostics Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 19. Global Diabetes Therapeutics and Diagnostics Sales Value by Application (2019-2024) & (US$ Million)

Table 20. Global Diabetes Therapeutics and Diagnostics Sales Value by Application (2025-2030) & (US$ Million)

Table 21. Global Diabetes Therapeutics and Diagnostics Sales Market Share in Value by Application (2019-2024) & (%)

Table 22. Global Diabetes Therapeutics and Diagnostics Sales Market Share in Value by Application (2025-2030) & (%)

Table 23. Global Diabetes Therapeutics and Diagnostics Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 24. Global Diabetes Therapeutics and Diagnostics Sales Value by Region (2019-2024) & (US$ Million)

Table 25. Global Diabetes Therapeutics and Diagnostics Sales Value by Region (2025-2030) & (US$ Million)

Table 26. Global Diabetes Therapeutics and Diagnostics Sales Value by Region (2019-2024) & (%)

Table 27. Global Diabetes Therapeutics and Diagnostics Sales Value by Region (2025-2030) & (%)

Table 28. Key Countries/Regions Diabetes Therapeutics and Diagnostics Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 29. Key Countries/Regions Diabetes Therapeutics and Diagnostics Sales Value, (2019-2024) & (US$ Million)

Table 30. Key Countries/Regions Diabetes Therapeutics and Diagnostics Sales Value, (2025-2030) & (US$ Million)

Table 31. 77 Elektronika Kft. Basic Information List

Table 32. 77 Elektronika Kft. Description and Business Overview

Table 33. 77 Elektronika Kft. Diabetes Therapeutics and Diagnostics Products, Services and Solutions

Table 34. Revenue (US$ Million) in Diabetes Therapeutics and Diagnostics Business of 77 Elektronika Kft. (2019-2024)

Table 35. 77 Elektronika Kft. Recent Developments

Table 36. A. Menarini Diagnostics S.R.L Basic Information List

Table 37. A. Menarini Diagnostics S.R.L Description and Business Overview

Table 38. A. Menarini Diagnostics S.R.L Diabetes Therapeutics and Diagnostics Products, Services and Solutions

Table 39. Revenue (US$ Million) in Diabetes Therapeutics and Diagnostics Business of A. Menarini Diagnostics S.R.L (2019-2024)

Table 40. A. Menarini Diagnostics S.R.L Recent Developments

Table 41. Abbott Laboratories Basic Information List

Table 42. Abbott Laboratories Description and Business Overview

Table 43. Abbott Laboratories Diabetes Therapeutics and Diagnostics Products, Services and Solutions

Table 44. Revenue (US$ Million) in Diabetes Therapeutics and Diagnostics Business of Abbott Laboratories (2019-2024)

Table 45. Abbott Laboratories Recent Developments

Table 46. Agamatrix Inc. Basic Information List

Table 47. Agamatrix Inc. Description and Business Overview

Table 48. Agamatrix Inc. Diabetes Therapeutics and Diagnostics Products, Services and Solutions

Table 49. Revenue (US$ Million) in Diabetes Therapeutics and Diagnostics Business of Agamatrix Inc. (2019-2024)

Table 50. Agamatrix Inc. Recent Developments

Table 51. Animas Corp. Basic Information List

Table 52. Animas Corp. Description and Business Overview

Table 53. Animas Corp. Diabetes Therapeutics and Diagnostics Products, Services and Solutions

Table 54. Revenue (US$ Million) in Diabetes Therapeutics and Diagnostics Business of Animas Corp. (2019-2024)

Table 55. Animas Corp. Recent Developments

Table 56. Ascensia Basic Information List

Table 57. Ascensia Description and Business Overview

Table 58. Ascensia Diabetes Therapeutics and Diagnostics Products, Services and Solutions

Table 59. Revenue (US$ Million) in Diabetes Therapeutics and Diagnostics Business of Ascensia (2019-2024)

Table 60. Ascensia Recent Developments

Table 61. Becton Dickinson Basic Information List

Table 62. Becton Dickinson Description and Business Overview

Table 63. Becton Dickinson Diabetes Therapeutics and Diagnostics Products, Services and Solutions

Table 64. Revenue (US$ Million) in Diabetes Therapeutics and Diagnostics Business of Becton Dickinson (2019-2024)

Table 65. Becton Dickinson Recent Developments

Table 66. Debiotech S.A. Basic Information List

Table 67. Debiotech S.A. Description and Business Overview

Table 68. Debiotech S.A. Diabetes Therapeutics and Diagnostics Products, Services and Solutions

Table 69. Revenue (US$ Million) in Diabetes Therapeutics and Diagnostics Business of Debiotech S.A. (2019-2024)

Table 70. Debiotech S.A. Recent Developments

Table 71. Eli Lilly And Co. Basic Information List

Table 72. Eli Lilly And Co. Description and Business Overview

Table 73. Eli Lilly And Co. Diabetes Therapeutics and Diagnostics Products, Services and Solutions

Table 74. Revenue (US$ Million) in Diabetes Therapeutics and Diagnostics Business of Eli Lilly And Co. (2019-2024)

Table 75. Eli Lilly And Co. Recent Developments

Table 76. Glaxo Smithkline Basic Information List

Table 77. Glaxo Smithkline Description and Business Overview

Table 78. Glaxo Smithkline Diabetes Therapeutics and Diagnostics Products, Services and Solutions

Table 79. Revenue (US$ Million) in Diabetes Therapeutics and Diagnostics Business of Glaxo Smithkline (2019-2024)

Table 80. Glaxo Smithkline Recent Developments

Table 81. Inlight Solutions Inc. Basic Information List

Table 82. Inlight Solutions Inc. Description and Business Overview

Table 83. Inlight Solutions Inc. Diabetes Therapeutics and Diagnostics Products, Services and Solutions

Table 84. Revenue (US$ Million) in Diabetes Therapeutics and Diagnostics Business of Inlight Solutions Inc. (2019-2024)

Table 85. Inlight Solutions Inc. Recent Developments

Table 86. Johnson & Johnson Basic Information List

Table 87. Johnson & Johnson Description and Business Overview

Table 88. Johnson & Johnson Diabetes Therapeutics and Diagnostics Products, Services and Solutions

Table 89. Revenue (US$ Million) in Diabetes Therapeutics and Diagnostics Business of Johnson & Johnson (2019-2024)

Table 90. Johnson & Johnson Recent Developments

Table 91. Lifescan Inc. Basic Information List

Table 92. Lifescan Inc. Description and Business Overview

Table 93. Lifescan Inc. Diabetes Therapeutics and Diagnostics Products, Services and Solutions

Table 94. Revenue (US$ Million) in Diabetes Therapeutics and Diagnostics Business of Lifescan Inc. (2019-2024)

Table 95. Lifescan Inc. Recent Developments

Table 96. Medtronic Basic Information List

Table 97. Medtronic Description and Business Overview

Table 98. Medtronic Diabetes Therapeutics and Diagnostics Products, Services and Solutions

Table 99. Revenue (US$ Million) in Diabetes Therapeutics and Diagnostics Business of Medtronic (2019-2024)

Table 100. Medtronic Recent Developments

Table 101. Merck & Co. Basic Information List

Table 102. Merck & Co. Description and Business Overview

Table 103. Merck & Co. Diabetes Therapeutics and Diagnostics Products, Services and Solutions

Table 104. Revenue (US$ Million) in Diabetes Therapeutics and Diagnostics Business of Merck & Co. (2019-2024)

Table 105. Merck & Co. Recent Developments

Table 106. Merck KGAA Basic Information List

Table 107. Merck KGAA Description and Business Overview

Table 108. Merck KGAA Diabetes Therapeutics and Diagnostics Products, Services and Solutions

Table 109. Revenue (US$ Million) in Diabetes Therapeutics and Diagnostics Business of Merck KGAA (2019-2024)

Table 110. Merck KGAA Recent Developments

Table 111. Nipro Corp. Basic Information List

Table 112. Nipro Corp. Description and Business Overview

Table 113. Nipro Corp. Diabetes Therapeutics and Diagnostics Products, Services and Solutions

Table 114. Revenue (US$ Million) in Diabetes Therapeutics and Diagnostics Business of Nipro Corp. (2019-2024)

Table 115. Nipro Corp. Recent Developments

Table 116. Novartis Pharma Ag Basic Information List

Table 117. Novartis Pharma Ag Description and Business Overview

Table 118. Novartis Pharma Ag Diabetes Therapeutics and Diagnostics Products, Services and Solutions

Table 119. Revenue (US$ Million) in Diabetes Therapeutics and Diagnostics Business of Novartis Pharma Ag (2019-2024)

Table 120. Novartis Pharma Ag Recent Developments

Table 121. Novo Nordisk A/S Basic Information List

Table 122. Novo Nordisk A/S Description and Business Overview

Table 123. Novo Nordisk A/S Diabetes Therapeutics and Diagnostics Products, Services and Solutions

Table 124. Revenue (US$ Million) in Diabetes Therapeutics and Diagnostics Business of Novo Nordisk A/S (2019-2024)

Table 125. Novo Nordisk A/S Recent Developments

Table 126. Owen Mumford Ltd. Basic Information List

Table 127. Owen Mumford Ltd. Description and Business Overview

Table 128. Owen Mumford Ltd. Diabetes Therapeutics and Diagnostics Products, Services and Solutions

Table 129. Revenue (US$ Million) in Diabetes Therapeutics and Diagnostics Business of Owen Mumford Ltd. (2019-2024)

Table 130. Owen Mumford Ltd. Recent Developments

Table 131. Palco Labs Inc. Basic Information List

Table 132. Palco Labs Inc. Description and Business Overview

Table 133. Palco Labs Inc. Diabetes Therapeutics and Diagnostics Products, Services and Solutions

Table 134. Revenue (US$ Million) in Diabetes Therapeutics and Diagnostics Business of Palco Labs Inc. (2019-2024)

Table 135. Palco Labs Inc. Recent Developments

Table 136. Roche Basic Information List

Table 137. Roche Description and Business Overview

Table 138. Roche Diabetes Therapeutics and Diagnostics Products, Services and Solutions

Table 139. Revenue (US$ Million) in Diabetes Therapeutics and Diagnostics Business of Roche (2019-2024)

Table 140. Roche Recent Developments

Table 141. Sanofi Basic Information List

Table 142. Sanofi Description and Business Overview

Table 143. Sanofi Diabetes Therapeutics and Diagnostics Products, Services and Solutions

Table 144. Revenue (US$ Million) in Diabetes Therapeutics and Diagnostics Business of Sanofi (2019-2024)

Table 145. Sanofi Recent Developments

Table 146. Takeda Pharmaceutical Co. Ltd. Basic Information List

Table 147. Takeda Pharmaceutical Co. Ltd. Description and Business Overview

Table 148. Takeda Pharmaceutical Co. Ltd. Diabetes Therapeutics and Diagnostics Products, Services and Solutions

Table 149. Revenue (US$ Million) in Diabetes Therapeutics and Diagnostics Business of Takeda Pharmaceutical Co. Ltd. (2019-2024)

Table 150. Takeda Pharmaceutical Co. Ltd. Recent Developments

Table 151. Terumo Corp. Basic Information List

Table 152. Terumo Corp. Description and Business Overview

Table 153. Terumo Corp. Diabetes Therapeutics and Diagnostics Products, Services and Solutions

Table 154. Revenue (US$ Million) in Diabetes Therapeutics and Diagnostics Business of Terumo Corp. (2019-2024)

Table 155. Terumo Corp. Recent Developments

Table 156. Key Raw Materials Lists

Table 157. Raw Materials Key Suppliers Lists

Table 158. Diabetes Therapeutics and Diagnostics Downstream Customers

Table 159. Diabetes Therapeutics and Diagnostics Distributors List

Table 160. Research Programs/Design for This Report

Table 161. Key Data Information from Secondary Sources

Table 162. Key Data Information from Primary Sources

Table 163. Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Diabetes Therapeutics and Diagnostics Product Picture

Figure 2. Global Diabetes Therapeutics and Diagnostics Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Diabetes Therapeutics and Diagnostics Sales Value (2019-2030) & (US$ Million)

Figure 4. Diabetes Therapeutics and Diagnostics Report Years Considered

Figure 5. Global Diabetes Therapeutics and Diagnostics Players Revenue Ranking (2023) & (US$ Million)

Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Diabetes Therapeutics and Diagnostics Revenue in 2023

Figure 7. Diabetes Therapeutics and Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 8. Insulin Picture

Figure 9. Insulin Delivery Picture

Figure 10. Oral Hypoglycemic Drugs Picture

Figure 11. Diagnosis And Monitoring Picture

Figure 12. Others Picture

Figure 13. Global Diabetes Therapeutics and Diagnostics Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 14. Global Diabetes Therapeutics and Diagnostics Sales Value Market Share by Type, 2023 & 2030

Figure 15. Product Picture of Type 1 Diabetes

Figure 16. Product Picture of Type 2 Diabetes

Figure 17. Product Picture of Gestational Diabetes

Figure 18. Product Picture of Others

Figure 19. Global Diabetes Therapeutics and Diagnostics Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 20. Global Diabetes Therapeutics and Diagnostics Sales Value Market Share by Application, 2023 & 2030

Figure 21. North America Diabetes Therapeutics and Diagnostics Sales Value (2019-2030) & (US$ Million)

Figure 22. North America Diabetes Therapeutics and Diagnostics Sales Value by Country (%), 2023 VS 2030

Figure 23. Europe Diabetes Therapeutics and Diagnostics Sales Value (2019-2030) & (US$ Million)

Figure 24. Europe Diabetes Therapeutics and Diagnostics Sales Value by Country (%), 2023 VS 2030

Figure 25. Asia Pacific Diabetes Therapeutics and Diagnostics Sales Value (2019-2030) & (US$ Million)

Figure 26. Asia Pacific Diabetes Therapeutics and Diagnostics Sales Value by Country (%), 2023 VS 2030

Figure 27. South America Diabetes Therapeutics and Diagnostics Sales Value (2019-2030) & (US$ Million)

Figure 28. South America Diabetes Therapeutics and Diagnostics Sales Value by Country (%), 2023 VS 2030

Figure 29. Middle East & Africa Diabetes Therapeutics and Diagnostics Sales Value (2019-2030) & (US$ Million)

Figure 30. Middle East & Africa Diabetes Therapeutics and Diagnostics Sales Value by Country (%), 2023 VS 2030

Figure 31. Key Countries/Regions Diabetes Therapeutics and Diagnostics Sales Value (%), (2019-2030)

Figure 32. United States Diabetes Therapeutics and Diagnostics Sales Value, (2019-2030) & (US$ Million)

Figure 33. United States Diabetes Therapeutics and Diagnostics Sales Value by Type (%), 2023 VS 2030

Figure 34. United States Diabetes Therapeutics and Diagnostics Sales Value by Application (%), 2023 VS 2030

Figure 35. Europe Diabetes Therapeutics and Diagnostics Sales Value, (2019-2030) & (US$ Million)

Figure 36. Europe Diabetes Therapeutics and Diagnostics Sales Value by Type (%), 2023 VS 2030

Figure 37. Europe Diabetes Therapeutics and Diagnostics Sales Value by Application (%), 2023 VS 2030

Figure 38. China Diabetes Therapeutics and Diagnostics Sales Value, (2019-2030) & (US$ Million)

Figure 39. China Diabetes Therapeutics and Diagnostics Sales Value by Type (%), 2023 VS 2030

Figure 40. China Diabetes Therapeutics and Diagnostics Sales Value by Application (%), 2023 VS 2030

Figure 41. Japan Diabetes Therapeutics and Diagnostics Sales Value, (2019-2030) & (US$ Million)

Figure 42. Japan Diabetes Therapeutics and Diagnostics Sales Value by Type (%), 2023 VS 2030

Figure 43. Japan Diabetes Therapeutics and Diagnostics Sales Value by Application (%), 2023 VS 2030

Figure 44. South Korea Diabetes Therapeutics and Diagnostics Sales Value, (2019-2030) & (US$ Million)

Figure 45. South Korea Diabetes Therapeutics and Diagnostics Sales Value by Type (%), 2023 VS 2030

Figure 46. South Korea Diabetes Therapeutics and Diagnostics Sales Value by Application (%), 2023 VS 2030

Figure 47. Southeast Asia Diabetes Therapeutics and Diagnostics Sales Value, (2019-2030) & (US$ Million)

Figure 48. Southeast Asia Diabetes Therapeutics and Diagnostics Sales Value by Type (%), 2023 VS 2030

Figure 49. Southeast Asia Diabetes Therapeutics and Diagnostics Sales Value by Application (%), 2023 VS 2030

Figure 50. India Diabetes Therapeutics and Diagnostics Sales Value, (2019-2030) & (US$ Million)

Figure 51. India Diabetes Therapeutics and Diagnostics Sales Value by Type (%), 2023 VS 2030

Figure 52. India Diabetes Therapeutics and Diagnostics Sales Value by Application (%), 2023 VS 2030

Figure 53. Diabetes Therapeutics and Diagnostics Industrial Chain

Figure 54. Diabetes Therapeutics and Diagnostics Manufacturing Cost Structure

Figure 55. Channels of Distribution (Direct Sales, and Distribution)

Figure 56. Bottom-up and Top-down Approaches for This Report

Figure 57. Data Triangulation

KEY QUESTIONS ADDRESSED BY THE REPORT

What was the global market size of Diabetes Therapeutics and Diagnostics in 2030? zhanKai

The global market size of Diabetes Therapeutics and Diagnostics in 2030 was 143500 Million USD.

Which companies rank high in the global Diabetes Therapeutics and Diagnostics market? shouQi

What was the global market size of Diabetes Therapeutics and Diagnostics in 2024? shouQi

What is the annual compound growth rate of the global Diabetes Therapeutics and Diagnostics market size from 2024 to 2030? shouQi

Which region is expected to have the highest market share? shouQi

Related Reports

Diabetes Therapeutics and Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Diabetes Therapeutics and Diagnostics was estimated to be worth US$ 129370 million in 2025 and is projected to reach US$ 153410 million, growing at a CAGR of 2.5% from 2026 to 2032.
Published Date: 2026-07-15
Pages: 152
USD 3950.00
(Single User License)
Global Diabetes Therapeutics and Diagnostics Market Research Report 2026
The global Diabetes Therapeutics and Diagnostics market was valued at US$ 129370 million in 2025 and is anticipated to reach US$ 153410 million by 2032, at a CAGR of 2.5% from 2026 to 2032.
Published Date: 2026-04-28
Pages: 144
USD 2900.00
(Single User License)
Global Diabetes Therapeutics and Diagnostics Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Diabetes Therapeutics and Diagnostics market size was US$ 126520 million in 2024 and is forecast to a readjusted size of US$ 150030 million by 2031 with a CAGR of 2.5% during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 120
USD 4250.00
(Single User License)
Diabetes Therapeutics and Diagnostics- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Diabetes Therapeutics and Diagnostics was estimated to be worth US$ 126520 million in 2024 and is forecast to a readjusted size of US$ 150030 million by 2031 with a CAGR of 2.5% during the forecast period 2025-2031.
Published Date: 2025-02-27
Pages: 141
USD 3950.00
(Single User License)
Global Diabetes Therapeutics and Diagnostics Market Research Report 2025
The global market for Diabetes Therapeutics and Diagnostics was valued at US$ 126520 million in the year 2024 and is projected to reach a revised size of US$ 150030 million by 2031, growing at a CAGR of 2.5% during the forecast period.
Published Date: 2025-02-27
Pages: 108
USD 2900.00
(Single User License)
Global Diabetes Therapeutics and Diagnostics Market Insights, Forecast to 2030
This report discusses the implications of the above-mentioned trends, in the context of the current size and growth of the diabetes market, in global terms as well as by the most important national markets. Companies in the relevant pharmaceutical and medical industries are discussed, with profiles of the leaders and an update on M&A activity. Five-year global sales forecasts are provided for the main drug and device categories, and breakdowns of the diabetes market are provided by country.
Published Date: 2024-04-15
Pages: 127
USD 4900.00
(Single User License)
Global Diabetes Therapeutics and Diagnostics Market Research Report 2024
This report discusses the implications of the above-mentioned trends, in the context of the current size and growth of the diabetes market, in global terms as well as by the most important national markets. Companies in the relevant pharmaceutical and medical industries are discussed, with profiles of the leaders and an update on M&A activity. Five-year global sales forecasts are provided for the main drug and device categories, and breakdowns of the diabetes market are provided by country.
Published Date: 2024-01-16
Pages: 108
USD 2900.00
(Single User License)

Diabetes Therapeutics and Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Diabetes Therapeutics and Diagnostics was estimated to be worth US$ 129370 million in 2025 and is projected to reach US$ 153410 million, growing at a CAGR of 2.5% from 2026 to 2032.
Published: 2026-07-15
Pages: 152
USD 3950.00 (Single User License)
Global Diabetes Therapeutics and Diagnostics Market Research Report 2026
The global Diabetes Therapeutics and Diagnostics market was valued at US$ 129370 million in 2025 and is anticipated to reach US$ 153410 million by 2032, at a CAGR of 2.5% from 2026 to 2032.
Published: 2026-04-28
Pages: 144
USD 2900.00 (Single User License)
Global Diabetes Therapeutics and Diagnostics Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Diabetes Therapeutics and Diagnostics market size was US$ 126520 million in 2024 and is forecast to a readjusted size of US$ 150030 million by 2031 with a CAGR of 2.5% during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 120
USD 4250.00 (Single User License)
Diabetes Therapeutics and Diagnostics- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Diabetes Therapeutics and Diagnostics was estimated to be worth US$ 126520 million in 2024 and is forecast to a readjusted size of US$ 150030 million by 2031 with a CAGR of 2.5% during the forecast period 2025-2031.
Published: 2025-02-27
Pages: 141
USD 3950.00 (Single User License)
Global Diabetes Therapeutics and Diagnostics Market Research Report 2025
The global market for Diabetes Therapeutics and Diagnostics was valued at US$ 126520 million in the year 2024 and is projected to reach a revised size of US$ 150030 million by 2031, growing at a CAGR of 2.5% during the forecast period.
Published: 2025-02-27
Pages: 108
USD 2900.00 (Single User License)
Global Diabetes Therapeutics and Diagnostics Market Insights, Forecast to 2030
This report discusses the implications of the above-mentioned trends, in the context of the current size and growth of the diabetes market, in global terms as well as by the most important national markets. Companies in the relevant pharmaceutical and medical industries are discussed, with profiles of the leaders and an update on M&A activity. Five-year global sales forecasts are provided for the main drug and device categories, and breakdowns of the diabetes market are provided by country.
Published: 2024-04-15
Pages: 127
USD 4900.00 (Single User License)
Global Diabetes Therapeutics and Diagnostics Market Research Report 2024
This report discusses the implications of the above-mentioned trends, in the context of the current size and growth of the diabetes market, in global terms as well as by the most important national markets. Companies in the relevant pharmaceutical and medical industries are discussed, with profiles of the leaders and an update on M&A activity. Five-year global sales forecasts are provided for the main drug and device categories, and breakdowns of the diabetes market are provided by country.
Published: 2024-01-16
Pages: 108
USD 2900.00 (Single User License)